Biotech

Latest Articles

Former Seagen CEO reveals brand new start-up Ottimo Pharma

.After antibody-drug conjugate (ADC) expert Seagen was sold to Pfizer last year for a whopping $43 b...

Ironwood creates additional bid for $1B GI medicine with brand new subgroup information

.On the heels of a stage 3 succeed that neglected to make an impression on clients, Ironwood Pharmac...

Novartis inks $150M bargain for autoimmune molecular glue

.Do not quit Monte Rosa Rehabs now. The Boston-based biotech is actually enjoying after authorizing ...

Jade carves out exec crew along with Chinook vets-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our summary of notable management hirings, shootings and...

Septerna goes social with upsized offering of $288M

.Commemorating his business's upsized initial public offering (IPO), Septerna chief executive office...

AbbVie creates Richter richer, paying for $25M to form discovery pact

.AbbVie has returned to the resource of its antipsychotic goliath Vraylar in search of yet another b...

GenSight enters into final weeks of money path as revenue flow slips by of range

.GenSight Biologics is weeks far from running out of loan. Once more. The biotech simply possesses s...

AZ licenses thrown away unusual health condition medicine to Monopar Therapeutics

.Monopar Rehabs is recuperating a medicine from the scrap heap of AstraZeneca's unusual disease pipe...

Arcus' brand-new HIF-2a data in renal cancer cells mention possible advantage over Merck's Welireg, analysts claim

.Along with new data out on Arcus Biosciences' speculative HIF-2a prevention, one team of experts es...

Roche wagers around $1B to grow Dyno gene treatment shipment treaty

.After developing a genetics treatment partnership along with Dyno Therapies in 2020, Roche is actua...

Lundbeck slashes market value of $250M Abide buyout after discomfort setback

.Lundbeck is slashing the book market value of its own $250 million Abide Therapeutics acquistion in...

Real- Globe Data Meets Medical Trial Style: Improving Process and also Website Selection

.The assimilation of real-world data (RWD) into protocol usefulness and site selection has emerged a...

Where are they right now? Catching up with previous Fierce 15 guest of honors

.At this year's Ferocious Biotech Peak in Boston, we caught up with forerunners in the biotech field...

Merck grabs preclinical DNA biotech for $1.3 B biobucks

.Merck &amp Co. is actually putting down $30 million beforehand to acquire Yale spinout Modifi Biosc...

Radiopharma Alpha-9 increases $175M series C to fund scientific push

.Alpha-9 Oncology has increased a $175 thousand set C cycle to stake its own clinical-stage radiopha...

Ocuphire to enhance into genetics therapy biotech using Piece purchase

.Eye medication manufacturer Ocuphire Pharma is actually getting genetics treatment developer Piece ...

Roche culls cough prospect, pivots KRAS course in Q3 update

.Roche's severe cough plan has sputtered to a stop. The drugmaker, which axed the program after the ...

Merck- Gilead long-acting oral combo reduces HIV for 48 full weeks

.Gilead Sciences and also Merck &amp Co. have actually led their once-weekly HIV combo treatment pas...

Lykos accepts FDA view that MDMA confirmation counts on new test

.Lykos Rehabs might possess dropped three-quarters of its own staff back the FDA's turndown of its o...

Septerna organizes $158M IPO to cash readouts for GPCR pipeline

.Septerna might be actually yet to divulge "any purposeful clinical data," but the biotech clearly a...